Trials / Completed
CompletedNCT02221141
Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Laurence Gabriel · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the prevalence in Belgium of Fabry disease in patients with unexplained hypertrophic cardiomyopathy measured by echocardiography and to determine in Fabry patients which was the most frequently initial symptom. Actually the early diagnosis is important because a treatment exists that can prevent future complications.
Conditions
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2014-08-20
- Last updated
- 2024-08-20
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02221141. Inclusion in this directory is not an endorsement.